معرفی
Jessie Neuckermans is a Postdoctoral Researcher specializing in Pharmaceutical and Pharmacological Sciences, with a focus on genetic and metabolic disorders. Her affiliations include roles under VLAIO Innovation mandates and FWO-funded research. She holds a PhD in Pharmaceutical Sciences (2016–2023) and a Master’s in Drug Development. Her research centers on Alkaptonuria and Tyrosinemia Type 1, leveraging gene therapy, in vitro models, and high-throughput screening. Key projects include the development of gene-based therapies and the EVOZymes platform. She has contributed to 25+ publications, with recent work addressing metabolic correction in mouse models and drug-tolerant enzyme variants. Awards include the FWO PhD fellowship (2016).
Activities highlight participation in international conferences (e.g., SSIEM 2024) and organization of events like the 12th International Scientific Conference on AKU. Supervision roles include mentoring students on topics like mRNA electroporation protocols and enzyme mutagenesis. Her work bridges preclinical development, drug screening, and translational medicine.
